Francesco Bellini OC, GU, Ph.D.

Background*

Dr. Francesco Bellini, OC, GU, Ph.D. is Co-founder of FB Health S.p.A. and serves as its Chairman and President. Dr. Bellini serves as an Officer of Order of Canada. He has considerable experience building a successful biopharmaceutical company. Dr. Bellini served as the Chief Executive Officer of BELLUS Health Inc. from December 2002 to January 1, 2010 and its President from January 20, 2005 to January 1, 2010. He co-founded Shire Canada, Inc. in 1986 and served as ... its Chairman from 1986 to May 2001, President from September 1986 to May 1998 and Chief Executive Officer from October 1986 to May 2001. From 1968 to 1984, he served as a Researcher at a Canadian subsidiary of Ayerst Inc. From 1968 to 1984, Dr. Bellini served as a Research Scientist of Ayerst Laboratories. He served as the Chairman and President of CliniChem Development Inc. since 1998. In 1984, he established the Biochemicals Division of the Institut Armand-Frappier at the Universite du Quebec. He served as the Chairman of BELLUS Health Inc. since December 2002. He serves as the Chairman of the Board at Prognomix, Inc. He has been Chairman of Picchio International Inc., and Picchio Pharma, Inc. since 2001. He served as Chairman of ViroChem Pharma Inc. He served as Chairman of BELLUS Health (Innodia) Inc. He served as the Chairman of Gentium S.p.A from November 2009 to December 7, 2009. He served as the Chairman of Adaltis Inc. until May 2008. He served as Vice Chairman of North American Vaccine Inc., since June 1991. He serves as a Director at Societe Generale de Financement. He serves as a Director of Picchio Pharma, Inc., Molson Coors Brewing Company (UK) Limited. He serves as Director of the Government of Canada's Science Technology Innovation Council. He served as a Director of BELLUS Health Inc. since 2002. He served as a Director of Molson Coors Brewing Company from February 2005 to June 4, 2014. He served as a Director of Sustainable Development Technology Canada and at Stem Cell Therapeutics Corp. from November 2007 to May 20, 2009. From 1984 to September of 1986, he served as Director of the Biochemicals Division of the Institut Armand-Frappier. He served as a Director of Shire Finance Ltd. and Adherex Technologies Inc. He served as a Director of Adaltis Inc., from 1991 to May 2008. He served as a Director of Shire Canada, Inc. since 1986. He served as a Director of Molson Inc. from May 8, 1997 to February 2005. He served as Director of Industrial Alliance Insurance and Financial Services Inc. He served as a Director of CliniChem Development Inc. since 1998. He served as a Non-Executive Director of Shire PLC from May 14, 2001 to May 10, 2003. He served as a Director of North American Vaccine Inc. since October 1989. He served as a Director of Uniforet Inc. He serves as a Director at Montreal Heart Institute Foundation and Italian Chamber of Commerce. Dr. Bellini is the Author or Co-author of approximately 25 patents and has published numerous articles and papers based on his research. He has an Honorary Degree - Doctor of Law, Concordia University, an Honorary degree - Doctor of University of Ottawa and an Honorary Degree - Doctor of Sciences University of New Brunswick. Dr. Bellini received his Bachelor of Science degree in Chemistry from Loyola College (now Concordia University) in 1972 and his PhD in Organic Chemistry from University of New Brunswick in 1977.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.